Other Headlines

The medical community pays tribute to a dedicated crew.
Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.
DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.
Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

House Passes Medicare Physician Payment Reform Act Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Scientists Find Unusual Immune System Activity in Brains of Schizophrenics The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Clinical PET-MRI Moves Closer to Reality Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Aural Trumps Oral for Ear Treatment A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Senate Health Care Reform Bill Unveiled Legislation may go to cloture vote this weekend. Read the details.

RSNA 2009 Preview This year's RSNA should provide a very interesting look at the effects of the economy on the major OEMs. As always, vendors are whipping up the hoopla, and inside this story are great previews of what's being debuted. But DOTmed reporters will also be there to get the real buzz. Look for video interviews in our Online News direct from the show.

Interview With Fred Robertson, President & CEO of TomoTherapy TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.

Health Care Reform Round-Up: CBO Pegs Senate Bill at $849 Billion The numbers are in on the Senate's version of reform. Also read about the wide-ranging impact that the legislation would have.

Pen-Sized Microscope Aims for Precise Brain Surgeries A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.

U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography Agency recommends no routine screening for women 40-49, no self-examination. Read the details.

A new kid on the block
in health technology

CareFusion Launches New Brand

by Barbara Kram, Editor
SAN DIEGO - CareFusion Corporation, the company that will become public following the planned spinoff of Cardinal Health's clinical and medical products businesses, today launched its new brand and marked the occasion by providing opportunities for its global employees to volunteer for non-profit organizations in their communities.

"This is an exciting day for our company and employees because we believe the opportunity we have to help hospitals measurably improve patient safety and the quality of patient care is of vital importance to the future of global health care," said David Schlotterbeck, chief executive officer of CareFusion. "We are focused on this opportunity as we develop proven medical technologies and combine them with the information our customers need to deliver a higher standard of patient care."

CareFusion Launches Brand

CareFusion's brand signifies the fusion of proven technologies with actionable intelligence to measurably improve care. The company's logo is in the shape of a shield to reflect the protection CareFusion provides to patients and clinicians. The two pieces of the shield represent the "fusion" of technology and intelligence integral to the company's mission, and the orange color was selected for its implication of "safety."

An advertising campaign launched today uses simple, recognizable symbols in a bold presentation against the company's signature orange color to highlight the value CareFusion brings to its customers. The print advertisements will appear more broadly in health care trade journals and national media beginning July 15.

CareFusion "Day of Caring"
The CareFusion "Day of Caring" is designed to encourage its employees to help bring its new brand and culture to life by giving back to the communities where they live and work. Employees at more than 20 locations worldwide will volunteer to support local charitable organizations. Many locations will be participating in a Foundation for Hospital Art PaintFest, where they will paint canvases that will be donated to local hospitals. Other non-profit organizations supported include local food banks, parks and health and human services agencies.

CareFusion Spinoff

CareFusion's planned spinoff from Cardinal Health is expected to be completed later this summer. As previously announced, the new company will be headquartered in San Diego and is anticipated to generate $3.8 billion1 in annual revenue. CareFusion's 15,000 employees globally will serve customers in 120 countries. Additional information regarding CareFusion and the planned spinoff can be found in the third amendment to its Form 10 registration statement filed with the U.S. Securities and Exchange Commission on June 26, 2009.

About CareFusion Corporation

CareFusion Corporation, a wholly owned subsidiary of Cardinal Health (NYSE:CAH), is expected to become a public company from the planned spinoff of Cardinal Health's clinical and medical products businesses. The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of health care. CareFusion develops market-leading technologies including Alaris IV pumps, Pyxis automated dispensing and patient identification systems, AVEA and Pulmonetic Systems ventilation and respiratory products, ChloraPrep and MedMined(tm) services for infection prevention, neurological monitoring and diagnostic products, V. Mueller surgical instruments, and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at www.carefusion.com.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED